REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Sandoz Ecuador S.A. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Sandoz Ecuador S.A. Profile Updated: September 08, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Sandoz Ecuador S.A. is an enterprise in Ecuador, with the main office in Quito. The company operates in the Pharmaceutical and Medicine Manufacturing industry. It was incorporated on October 17, 2022. Sandoz Ecuador S.A. currently employs 66 (2024) people. In 2025, the company reported a net sales revenue increase of 190.03%. During that time, Sandoz Ecuador S.A.’s total assets grew by 14.44%. In 2025, Sandoz Ecuador S.A.’s net profit margin decreased by 1.77%.

Headquarters
Calle Amazonas, N37 29
Quito; Pichincha;

Contact Details: Purchase the Sandoz Ecuador S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Sandoz Ecuador S.A. report to view the information.
Registered Capital:
Purchase the Sandoz Ecuador S.A. report to view the information.
Financial Auditors:
Purchase the Sandoz Ecuador S.A. report to view the information.
Incorporation Date:
October 17, 2022
Key Executives
Purchase this report to view the information.
Vice President
Ownership Details
Purchase this report to view the information.
99.99%
Purchase this report to view the information.
0.01%
Company Performance
Financial values in the chart are available after Sandoz Ecuador S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
190.03%▲
Total Operating Revenue
190.03%▲
Operating Profit
52.97%▲
EBITDA
73.89%▲
Net Profit/Loss for the Period
-36.82%▼
Total Assets
14.44%▲
Total Equity
6.9%▲
Operating Profit Margin
-1.87%▼
Net Profit Margin
-1.77%▼
Return on Equity (ROE)
-3.3%▼
Debt / Equity
1.61%▲
Quick Ratio
-0.13%▼
Cash Ratio
-0.06%▼

Similar companies

Quifatex S.A.
 
Laboratorios Siegfried S.A.
Roche Ecuador S.A.
 
Bayer S.A.
Nefrocontrol S.A.
 
Novartis Ecuador S.A.
Sanfer - Bussie Ecuador S.A.
 
Laboratorios Bi - Farma C.A.
Laboratorios Hg C.A.
 
Saleticlab S.A.
Jaspharm CIA Ltda
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo